ITPR1 and atrial fibrillation: Modulation of IP3R offers a promisingapproach not only to alleviate abnormal calcium signaling in AF but also to pavethe way for the development of precision molecular therapies for arrhythmias.This targeted approach holds potential for advancing AF treatment throughinnovative molecular design and tailored therapeutic strategies.